Opinion

Video

Medication Assistance Programs Mitigating Financial Burden For Patients Receiving Bispecific Therapy

Experts underscore cost relief of bispecific antibodies via medication assistance programs.

The following is a video synopsis/summary of a Peer Exchange involving Ryan Haumschild, PharmD, MS, MBA, CPEL; Kirollos Hanna, PharmD, BCPS, BCOP, FACCC; Sarah Rockwell, PharmD, BCOP; Melody Chang, RPh, MBA, BCOP; and Ryan Cain, PA-C.

Video synopsis is AI-generated and reviewed by AJMC editorial staff.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
EHA 2025 Congress Recap | Image Credit: Venngage
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo